Published in Autoimmunity on February 01, 2005
Surface plasmon resonance for high-throughput ligand screening of membrane-bound proteins. Biotechnol J (2009) 1.15
Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited. Diagn Pathol (2009) 1.14
Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. J Immunol Res (2014) 1.03
Immunofluorescence microscopy is superior to fluorescent beads for detection of antinuclear antibody reactivity in systemic lupus erythematosus patients. Clin Immunol (2007) 0.93
Comparison of indirect immunofluorescence and multiplex antinuclear antibody screening in systemic sclerosis. Clin Rheumatol (2011) 0.91
Highlights on novel technologies for the detection of antibodies to Ro60, Ro52, and SS-B. Clin Dev Immunol (2013) 0.88
Clinical associations of anti-CENP-B and anti-Scl70 antibody levels measured by multiplexed fluorescent microsphere immunoassay in systemic sclerosis. Rheumatol Int (2009) 0.81
Clinical comparison of QUANTA Flash dsDNA chemiluminescent immunoassay with four current assays for the detection of anti-dsDNA autoantibodies. J Immunol Res (2015) 0.78
Determination of ANA specificity using multiplexed fluorescent microsphere immunoassay in patients with ANA positivity at high titres after infliximab treatment: preliminary results. Rheumatol Int (2006) 0.75
Emerging technologies in autoantibody testing for rheumatic diseases. Arthritis Res Ther (2017) 0.75
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum (1997) 6.04
Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. N Engl J Med (1983) 4.43
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis (1996) 3.68
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus (2003) 3.61
Idiotypic cross-reactions of monoclonal human lupus autoantibodies. J Exp Med (1983) 2.96
Rheumatology in Israel. Br J Rheumatol (1996) 2.66
Serum antibodies in epilepsy and seizure-associated disorders. Neurology (2005) 2.53
Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet (1998) 2.31
Production of autoantibodies by human-human hybridomas. J Clin Invest (1982) 2.22
Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome. J Pediatr (1999) 2.10
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis (2010) 2.09
Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis. Arthritis Rheum (1995) 2.09
Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet (1984) 2.08
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) (2001) 2.02
Increased prevalence of joint manifestations in patients with recurrent aphthous stomatitis (RAS) Clin Exp Rheumatol (1997) 2.01
Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet (1998) 1.95
Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation (1996) 1.92
Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc Natl Acad Sci U S A (1988) 1.91
Colchicine treatment for recurrent pericarditis. A decade of experience. Circulation (1998) 1.87
MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid (1999) 1.81
Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A (1991) 1.77
Binding of cytoskeletal proteins by monoclonal anti-DNA lupus autoantibodies. Clin Immunol Immunopathol (1984) 1.76
Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut (2005) 1.73
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis (2009) 1.69
Diagnostic and treatment concerns in familial Mediterranean fever. Baillieres Best Pract Res Clin Rheumatol (2000) 1.59
No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J Rheumatol (1996) 1.58
Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis (2001) 1.55
Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus. Arthritis Rheum (1984) 1.53
Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis (2004) 1.53
Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis (2010) 1.52
Immunologic and genetic factors in autoimmune diseases. N Engl J Med (1984) 1.50
Elevated homocysteine levels in patients with Raynaud's syndrome. J Rheumatol (1999) 1.49
The prevalence of coeliac disease antibodies in patients with the antiphospholipid syndrome. Lupus (2003) 1.48
Detection of cross-reactive anti-DNA antibody idiotypes in the serum of systemic lupus erythematosus patients and of their relatives. Arthritis Rheum (1985) 1.48
Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis (2003) 1.48
Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity. Ann Rheum Dis (2005) 1.48
Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant (1998) 1.47
Autoantibodies in neoplasia. An unresolved enigma. Cancer (1990) 1.45
Role of beta 2-glycoprotein I in the antiphospholipid antibody binding to endothelial cells. Lupus (1995) 1.44
The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome--molecular mimicry? J Rheumatol (2000) 1.44
Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis (2005) 1.44
Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation. The importance of the T cell. Arthritis Rheum (1995) 1.44
The good, the bad and the ugly of vaccination. Isr Med Assoc J (2000) 1.43
Clinical characteristics of ruptured chordae tendineae in hospitalized patients: primary tear versus infective endocarditis. Clin Cardiol (1998) 1.42
A multidimensional autoantibody analysis specifying systemic lupus erythematosus patients with neuropsychiatric symptomatology. Isr J Med Sci (1992) 1.41
High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis. Semin Arthritis Rheum (1998) 1.40
Superior vena cava occlusion in a patient with antiphospholipid antibody syndrome. J Rheumatol (1991) 1.40
Presence of a 16/6 related human anti-DNA common idiotype (SA1) in the anticardiolipin antibodies of patients with primary antiphospholipid syndrome. J Rheumatol (1991) 1.40
Low dose aspirin in patients with ischemic heart disease may precipitate secondary myocardial infarction. Isr J Med Sci (1996) 1.40
Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest (1992) 1.39
Antiphospholipid antibody testing - slow progress? Int J Clin Pract (2012) 1.39
Reversal of the nephrotic syndrome by colchicine in amyloidosis of familial Mediterranean fever. Ann Intern Med (1992) 1.39
[Viagra--the first oral treatment for impotence that is not lacking in fatal effects]. Harefuah (1998) 1.38
Effects of exposure to Finnish sauna. Isr J Med Sci (1976) 1.37
Mycobacteria and autoimmunity. Immunol Today (1988) 1.36
Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatology (Oxford) (2006) 1.35
A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response. Lupus (1999) 1.31
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis (2008) 1.28
Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis (1998) 1.26
Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state. Am J Med Genet (2001) 1.23
The mosaic of autoimmunity. Immunol Today (1989) 1.23
Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies. Ann N Y Acad Sci (2005) 1.22
Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65. Arterioscler Thromb Vasc Biol (1999) 1.21
Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus (1999) 1.21
Reliability of measurements of active and damaged joints in psoriatic arthritis. J Rheumatol (1990) 1.20
Common FMF alleles may predispose to development of Behcet's disease with increased risk for venous thrombosis. Scand J Rheumatol (2007) 1.19
Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies. J Immunol (1994) 1.19
Systemic lupus erythematosus one disease or many? Autoimmun Rev (2011) 1.18
Gaucher's disease: a disease with chronic stimulation of the immune system. Arch Pathol Lab Med (1982) 1.17
Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum (1996) 1.17
Activation of the cytokine network in familial Mediterranean fever. J Rheumatol (1999) 1.16
Detection of antibodies to total histones and their subfractions in systemic lupus erythematosus patients and their asymptomatic relatives. Arthritis Rheum (1987) 1.16
The changing face of familial Mediterranean fever. Semin Arthritis Rheum (1996) 1.16
Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression. Ann Rheum Dis (2010) 1.15
Prevalence of hypophosphatemia in sepsis and infection: the role of cytokines. Am J Med (1998) 1.14
Behçet's disease in Familial Mediterranean fever: characterization of the association between the two diseases. Semin Arthritis Rheum (2000) 1.14
What causes alopecia areata? Exp Dermatol (2013) 1.14
The dual association between lymphoma and autoimmunity. Blood Cells Mol Dis (2002) 1.14
Cold-induced profuse sweating on back and chest. A new genetic entity? Lancet (1978) 1.14
Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann N Y Acad Sci (2007) 1.14
Treatment of pregnant patients with antiphospholipid syndrome. Lupus (2003) 1.13
Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol (1999) 1.13
Antiphospholipid syndrome induced by HIV. Lupus (2001) 1.13